Mustang Bio Inc. Common Stock (MBIO)
Stock · NASDAQ · Health Care
$0.376as of 10/16/2026
Price chart
Active signals
MBIO Signal Track Record
How signals performed across all stocks →What MBIO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 26 | -2.3% | 38% | September 30, 2026 |
| Volume Spike | 22 | -17.2% | 27% | October 9, 2026 |
| Bollinger Band Breakout | 13 | -21.0% | 15% | October 7, 2025 |
| Any 20-session window (baseline) | -11.9% | 27% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MBIO
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination M…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4
- Website
- www.mustangbio.com/
Fundamentals
- 1-day range
- $0.3701$0.3923
- Market cap
- $3.87M
- P/E (trailing)
- —
- P/E (forward)
- -1.10
- EPS (trailing)
- $-0.46
- Dividend yield
- —
- Beta
- 2.19
- Avg. volume
- 31.9K
Mustang Bio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MBIOMustang Bio Inc. Common Stock$0.376▼ 2.59%Market cap $3.87MP/E —$0.3701$1.69
- SPRCSciSparc Ltd. Ordinary Shares$1.7▼ 15.00%Market cap $3.85MP/E —$1.63$43.65
- INMInMed Pharmaceuticals Inc. Common Shares$1.32▼ 0.75%Market cap $4.01MP/E —$0.575$2.33
- RDHLRedhill Biopharma Ltd. American Depositary Shares$0.48▼ 3.81%Market cap $3.53MP/E Infinity$0.4351$2.14
- XRTXXORTX Therapeutics Inc. Common Shares$1.24▼ 12.68%Market cap $3.51MP/E —$2.42$9.85
- JUNSJupiter Neurosciences Inc. Common Stock$2.9▼ 7.48%Market cap $4.24MP/E —$2.25$135.75
- ELABPMGC Holdings Inc. Common Stock$2.77▼ 8.88%Market cap $4.34MP/E —$2.59$2,671
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MBIO Mustang Bio Inc. Common Stock | $3.87M | — | $0.376 | ▼ 2.59% | $0.3701$1.69 |
| SPRC SciSparc Ltd. Ordinary Shares | $3.85M | — | $1.7 | ▼ 15.00% | $1.63$43.65 |
| INM InMed Pharmaceuticals Inc. Common Shares | $4.01M | — | $1.32 | ▼ 0.75% | $0.575$2.33 |
| RDHL Redhill Biopharma Ltd. American Depositary Shares | $3.53M | Infinity | $0.48 | ▼ 3.81% | $0.4351$2.14 |
| XRTX XORTX Therapeutics Inc. Common Shares | $3.51M | — | $1.24 | ▼ 12.68% | $2.42$9.85 |
| JUNS Jupiter Neurosciences Inc. Common Stock | $4.24M | — | $2.9 | ▼ 7.48% | $2.25$135.75 |
| ELAB PMGC Holdings Inc. Common Stock | $4.34M | — | $2.77 | ▼ 8.88% | $2.59$2,671 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Litchman Manuel MD · April 24, 2026 · Tax Withholding19 @ $0.75
Institutional Ownership
March 31, 2026
- Total shares held
- 475.9K
- Total value held
- $346.5K
- Institutional holders
- 20
- Unknown176.0K
- Unknown92.8K
- Unknown84.7K
- Unknown53.2K
- Unknown25.7K
- Unknown20.5K
- Unknown16.8K
- Unknown3.7K
- Unknown1.9K
- Unknown509
See the full, filterable feed with live charts on the MarketWall dashboard.